Hemagen Diagnostics, Inc. (HMGN) Stock Price & Analysis
Hemagen Diagnostics, Inc. (HMGN) closed at USD 0 on Friday, October 23, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0; the Oct 23, 2026 session ranged USD 0.02–0.02 on volume of 50,000 shares. Market capitalization is $3,100, with a 52-week range of USD 0–0.13 (PNK). Source: Nexqual, retrieved October 25, 2026 at 00:22 UTC.
Also available as compact Markdown for AI agents: nexqual.com/HMGN.md
Key facts (HMGN)
- Analysts: None.
- Total return with dividends: 1Y +100.0% vs S&P 500 +13.4%; 5Y +100.0% vs S&P 500 +76.9%.
Analysts (HMGN)
Consensus None.
Total return (dividends reinvested) (HMGN)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +100.0% | +100.0% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +100.5% | +14.9% |
| Volatility (annualized) | 466.4% | 207.3% |
| Max drawdown | -92.3% (Jun 2026→Jul 2026) | -92.3% (Jun 2026→Jul 2026) |
HMGN analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |
Key Statistics (as of October 25, 2026 at 00:22 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0.02 |
| Day Range | USD 0.02 – 0.02 |
| 52-Week Range | USD 0 – 0.13 |
| Volume | 50,000 shares |
| Market Cap | $3,100 |
| Exchange | PNK |
Technical Analysis (HMGN)
Nexqual's technical model rates HMGN "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 25, 2026 at 00:22 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (HMGN)
Wall Street analysts rate HMGN "None", per Nexqual as of October 25, 2026 at 00:22 UTC.
| Consensus Rating | None |
|---|
Earnings (HMGN)
Source: Nexqual, October 25, 2026 at 00:22 UTC.
Financials & Fundamentals (HMGN)
| Total Revenue | $4.04M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -23.60% |
| Gross Margin | +39.92% |
| Operating Margin | -4.99% |
| Profit Margin | -22.45% |
| Current Ratio | 1.07 |
| Total Cash | $66,287 |
| Total Debt | $5.03M |
Source: Nexqual, October 25, 2026 at 00:22 UTC.
Financial Health Score (HMGN)
Nexqual rates Hemagen Diagnostics, Inc.'s overall financial health "Weak" across five dimensions, as of October 25, 2026 at 00:22 UTC.
| Growth | Critical — Revenue -24% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $66K cash vs $5M debt |
| Cash Flow | Weak — Operating cash flow -$359K (TTM) |
| Efficiency | Mixed — No data |
Ownership (HMGN)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 15.50M |
Source: Nexqual, October 25, 2026 at 00:22 UTC.
Leadership (HMGN)
Hemagen Diagnostics, Inc. is led by William P. Hales, Executive Chairman, CEO & President, per Nexqual as of October 25, 2026 at 00:22 UTC.
| Executive Chairman, CEO & President | William P. Hales |
|---|---|
| CFO & COO | M. Robert Campbell |
Major Backers & Investors (HMGN)
Notable institutional backers of Hemagen Diagnostics, Inc. include Formidable Asset Management, Llc, according to Nexqual as of October 25, 2026 at 00:22 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Formidable Asset Management, Llc | 0.33% |
Source: Nexqual, October 25, 2026 at 00:22 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Incorpor | USD 303.53 | ▼ 1.39% |
| RYTM | Rhythm Pharmaceuticals, Inc. | USD 89.27 | ▼ 1.79% |
| IOVA | Iovance Biotherapeutics, Inc. | USD 14.09 | ▼ 0.35% |
| PRAX | Praxis Precision Medicines, Inc | USD 252.96 | ▼ 2.3% |
| IONS | Ionis Pharmaceuticals, Inc. | USD 42.93 | ▼ 2.23% |
| AXSM | Axsome Therapeutics, Inc. | USD 145.04 | ▼ 7.07% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 25, 2026 at 00:22 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt